Belif Lab, the agency of the group Eyelet, announced its position on the ‘New Genes plagiarism suspicion’ by Min Hee-jin, executive director of Adore.
On the 11th, Belif Lab provided an explanation to News 1, saying, “The claim that Aylet plagiarized New Genes’ plan is not true.”
In response to this, Belif Lab said, “Islet’s branding strategy and concept were finalized and shared internally on July 21, 2023.” It was after that, on August 28, 2023, that the informant sent the so-called ‘planning plan’. , Due to the point of view, it is not possible to influence the concept of Aillet.”
Earlier on this day, Director Min Hee-jin’s side said at the preliminary injunction hearing, including voting rights exercise, heard by Seoul Central District Court Civil Settlement Division 50 (Chief Judge Sang-hoon Kim), “An employee within Hive said that the Eyelet creative director requested New Jeans’ plan from the Eyelet conception stage. “I reported that Aylet’s plan was identical to New Genes’ plan,” he claimed.
In relation to this, Director Min Hee-jin said, “The informant delivered the materials at the request of the creative director of Eyelet, but he said, ‘I never imagined that they would be made in the same way. It seems that all the same materials have been submitted to the court. I looked at all of these and referred to them, so why do they keep saying no? He also said, “I’m uncomfortable with Belif Lab’s claim that the plagiarism suspicion is false.”
Previously, Adore announced on August 27, “We held a board meeting on this day and appointed Adore executive director Kim Joo-young as the new CEO.” He continued, “The new CEO, Kim Joo-young, is a human resources management (HR) expert with experience in various industries and will take on the role of stabilizing Adore’s organization and internal reorganization.”
Adore said, “Former CEO Min Hee-jin will step down as CEO, but will remain as an executive director of Adore,” and “She will also continue to take charge of New Jeans’ producing duties.” In addition, “Adore’s internal organization will also separate production and management,” he said. “This has been a multi-label operation principle that has been consistently applied to all other labels (within Hive), but Adore has been the exception, with the CEO overseeing both production and management.” “We have done it,” he emphasized.
However, Executive Director Min Hee-jin objected to this, saying, “This decision to dismiss is an illegal decision that directly contradicts the contract between shareholders and the decision to injunction to ban the exercise of voting rights.” He then claimed, “CEO Min Hee-jin was dismissed against her will and did not step down,” adding, “The Adore board of directors just unilaterally notified her that she would be put in charge of producing duties.”
Afterwards, on September 11, New Genes conducted a live broadcast on YouTube and requested Hive to reinstate executive director Min to the position of CEO of Adore by September 25.
On September 13, Director Min Hee-jin also announced her intention to enter into litigation once again, requesting reinstatement as CEO and filing a lawsuit against Hive for a provisional injunction, including the exercise of voting rights.
(Seoul = News 1)
-
- great
- 0dog
-
- I’m sad
- 0dog
-
- I’m angry
- 0dog
-
- I recommend it
- dog